Part Details | LORAZEPAM INJECTION
6505-01-650-1467
Alternate Parts: NDC76329826101, NDC76329-8261-01, 1389217, 6505NCM152482, NDC00409678002, NDC00409-6780-02, NDC00641605010, NDC00641-6050-10, NDC00641604610, NDC00641-6046-10, NDC00641600010, NDC00641-6000-10, 6505-01-650-1467, 01-650-1467, 6505016501467, 016501467
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | NOV 20, 2015 | 01-650-1467 | 50832 ( LORAZEPAM INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-650-1467
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC76329-8261-01 | 3FFJ6 | AMPHASTAR PHARMACEUTICALS, INC. |
| 1389217 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM152482 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC00409-6780-02 | 3VBU6 | HOSPIRA, INC. |
| NDC00641-6050-10 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
| NDC00641-6046-10 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
| NDC00641-6000-10 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
Technical Data | NSN 6505-01-650-1467
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER CONTENT QUANTITY | 10.0 EACH |
| PRIMARY CONTAINER TYPE | VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY10.0 MILLIGRAMS LORAZEPAM |
| PHARMACEUTICAL VEHICLE TYPE | B ANY ACCEPTABLE |
| ADMINISTRATION | B$K OTIC IRRIGATION |
| SPECIAL FEATURES | STRENGTH: 20 MG/ 10 ML; FILL VOLUME/UNIT SIZE: 10 ML; PACKAGE QUANTITY: 10 VIALS; MULTI DOSE VIAL; SCHEDULE IV DEA CONTROLLED SUBSTANCE; INTENDED FOR THE INTRAMUSCULAR OR INTRAVENOUS ROUTES OF ADMINISTRATION; EACH ML OF STERILE INJECTION CONTAINS EITHER 2 MILLIGRAMS OF LORAZEPAM; PROTECT FROM LIGHT; STORE IN REFRIGERATOR 2 TO 8 C (36 TO 46 F) |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LORAZEPAM 20 MG/10 ML VIAL 10ML |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |